Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA, ex. rel., William St. John LaCorte, M.D., et al. v. Wyeth
Case Number:
1:06-cv-11724
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Arrowood LLP
- Baker Donelson
- Deutsch Kerrigan
- Fox Rothschild
- Gesmer Updegrove
- Gilman McLaughlin
- Kellogg Hansen
- Lieff Cabraser
- Lurie Friedman
- Quinn Emanuel
- Ropes & Gray
- Sakla Law Firm
- Stanley Reuter
- Todd & Weld
- Vezina Law
- WilmerHale
Companies
Government Agencies
Sectors & Industries:
-
December 14, 2023
Judge Divvies Up Atty Fees From $785M FCA Deal
A Massachusetts federal judge issued a more than 70-page finding of facts Thursday settling an attorney fee dispute over $21 million from a seven-year-old judgment, saying two firms earned portions of what they sought for their early work on the case.
-
January 22, 2018
Attorneys Squabble Over Cut Of $785M Pfizer FCA Deal
Attorneys who were fired less than halfway into a whistleblower case against a Pfizer subsidiary went to trial Monday to bicker over who should get credit for resolving the False Claims Act lawsuit and $21 million in outstanding attorneys' fees that go with its $785 million settlement.
-
January 08, 2018
Doc's Attys Duel Over Fee Split In $785M Pfizer FCA Deal
Three firms that represented a whistleblower in a False Claims Act suit against a Pfizer subsidiary on Monday set the stage for an upcoming civil trial over fees with briefs disputing whether two firms that were fired eight years before the case settled for $785 million should be entitled to a large chunk of the winnings.
-
May 10, 2017
Pfizer Settles Fee Dispute In $785M FCA Deal
Pfizer Inc. and a relator who blew the whistle on false claims have agreed to resolve their dispute over how much in attorneys' fees the company should pay after its $785 million settlement.
-
December 21, 2016
Firms Fight For Equal Fees In $785M Pfizer FCA Deal
Two of three law firms that represented a whistleblowing doctor who helped win a $785 million False Claims Act settlement with Pfizer Inc. were back in court Wednesday gunning for an equal share of the $37 million allocated for attorneys' fees in the labyrinthine litigation.
-
November 29, 2016
Whistleblower In $785M Pfizer FCA Deal Agrees To Fees Split
A whistleblowing doctor who helped win a $785 million False Claims Act settlement with Pfizer Inc. agreed with his former lawyers Tuesday on a split of attorneys' fees, resolving one of several disputes about paying a battalion of attorneys.
-
September 02, 2015
Mass. Judge Says Pfizer Whistleblower Suit Likely To Proceed
The Massachusetts federal judge overseeing two consolidated whistleblower suits accusing the pharmaceutical arm of Pfizer Inc. of overcharging state Medicaid programs hundred of millions of dollars for the acid reflux drug Protonix said Tuesday he was inclined to deny the company's four-year-old motion for summary judgment.